All In MedTech

Device Trial Radar · NCT04972097

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population

Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

121

Actual

Start

Mar 29, 2022

Primary completion

Aug 14, 2024

Study completion Aug 14, 2024

Sponsor

Lead sponsor
Angiodynamics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 22, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pivotal study to evaluate the use of the NanoKnife System as a focal therapy option for prostate cancer patients. This study will assess the safety and effectiveness of the device when used to ablate prostate tissue in intermediate-risk prostate cancer patients.

Conditions

  • Prostate Cancer

Interventions

  • Irreversible ElectroporationDevice

    IRE of the prostate is typically performed with the subject in the lithotomy position, with 2-6 monopolar probes placed through the perineum using a brachytherapy grid and ultrasound or CT guidance. IRE supplies the targeted tissue with high voltage (2-3 kV) direct current pulses lasting up to 100 microseconds through the electrode probes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With a Negative In-field Biopsy at 12 MonthsTime frame: 12 months
  2. Number of Participants With Device-related Adverse Events Through 12 MonthsTime frame: 12 months

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • University of California Irvine

    Orange, California

  • University of Colorado

    Aurora, Colorado

  • University of Florida Health

    Gainesville, Florida

14 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.